4-Bromo-2-fluorotoluene - CAS 51436-99-8
Catalog: |
BB027438 |
Product Name: |
4-Bromo-2-fluorotoluene |
CAS: |
51436-99-8 |
Synonyms: |
4-bromo-2-fluoro-1-methylbenzene |
IUPAC Name: | 4-bromo-2-fluoro-1-methylbenzene |
Description: | 4-Bromo-2-fluorotoluene (CAS# 51436-99-8) is a useful research chemical. |
Molecular Weight: | 189.02 |
Molecular Formula: | C7H6BrF |
Canonical SMILES: | CC1=C(C=C(C=C1)Br)F |
InChI: | InChI=1S/C7H6BrF/c1-5-2-3-6(8)4-7(5)9/h2-4H,1H3 |
InChI Key: | YZFVUQSAJMLFOZ-UHFFFAOYSA-N |
Boiling Point: | 68 °C (8 mmHg) |
Purity: | 97 % |
Density: | 1.492 g/cm3 |
Appearance: | Colorless to light yellow liqui |
Storage: | Keep away from sources of ignition. Store in a cool, dry place. Store in a tightly closed container. |
MDL: | MFCD00013551 |
LogP: | 2.89660 |
GHS Hazard Statement: | H302 (85.11%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021083209-A1 | Ssao inhibitors and use thereof | 20191029 |
EP-3782997-A1 | Fused pyrimidine compounds and pharmaceutical compositions thereof for the treatment of fibrotic diseases | 20190819 |
WO-2021009068-A1 | N-substituted-3,4-(fused 5-ring)-5-phenyl-pyrrolidine-2-one compounds as inhibitors of isoqc and/or qc enzyme | 20190712 |
WO-2020248279-A1 | Continuous synthesis method for substituted benzoate organic matter | 20190614 |
WO-2020198266-A1 | Small molecule inhibitors of galectin-3 | 20190326 |
PMID | Publication Date | Title | Journal |
20936791 | 20101111 | A diverse series of substituted benzenesulfonamides as aldose reductase inhibitors with antioxidant activity: design, synthesis, and in vitro activity | Journal of medicinal chemistry |
17009299 | 20061001 | Synthesis and aldose reductase inhibitory activities of novel O-substituted hydroxyphenylacetic acid derivatives | Archiv der Pharmazie |
17009300 | 20061001 | Discovery of novel aldose reductase inhibitors characterized by an alkoxy-substituted phenylacetic acid core | Archiv der Pharmazie |
11444967 | 20010727 | Stereospecific interaction of a novel spirosuccinimide type aldose reductase inhibitor, AS-3201, with aldose reductase | Biochemistry |
Complexity: | 94.9 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 187.96369 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 187.96369 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 0 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 3.1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Fluorinated Building Blocks
-
[1427357-61-6]
6-Fluoro-[1,2,4]triazolo[1,5-a]pyridine
-
[1006473-17-1]
[(2,3-Difluorophenyl)methyl][(1,3-dimethylpyrazol-4-yl)methyl]amine
-
[1106917-71-8]
[3-(Difluoromethoxy)phenyl]methanamine hydrochloride
-
[1866059-82-6]
1,1,2,2-Tetrafluoro-3-methylsulfonylpropane
-
[479552-94-8]
1H-Pyrrolo[2,3-b]pyridin-4-yl trifluoromethanesulfonate
-
[2454490-85-6]
2-(7,8-Difluoro-1-naphthyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Halides
Other Pyrimidines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS